Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuting Sang
Observed name:
Yu-ting Sang
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Huashan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Shandong University,
Fudan University,
Fudan University Shanghai Cancer Center,
Huashan Hospital,
Qilu Hospital of Shandong University
show all 6
ORCID:
0000-0003-1007-6378
Observed ORCID:
0000-0003-1007-6378
OpenAlex ID:
A5091223860
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
2019
·
Yuting Sang
, Bing Chen
, et al.
·
Molecular Therapy
·
500
PDF
LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215
2018
·
Xiaoli Kong
, Yi Duan
, et al.
·
Journal of Cellular Physiology
·
302
Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28
2021
·
Bing Chen
, Yuting Sang
, et al.
·
Theranostics
·
242
MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
2018
·
Yaming Li
, Yiran Liang
, et al.
·
Cell Death and Disease
·
189
PDF
circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer
2019
·
Yiran Liang
, Xiaojin Song
, et al.
·
Oncogene
·
162
Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer
2019
·
Hanwen Zhang
, Ning Zhang
, et al.
·
Cancer Research
·
142
A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer
2018
·
Yiran Liang
, Xiaojin Song
, et al.
·
Cell Death and Disease
·
99
PDF
Targeting the circBMPR2/miR-553/USP4 Axis as a Potent Therapeutic Approach for Breast Cancer
2019
·
Yiran Liang
, Xiaojin Song
, et al.
·
Molecular Therapy — Nucleic Acids
·
94
PDF
Correction: Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer
2021
·
Hanwen Zhang
, Ning Zhang
, et al.
·
Cancer Research
·
92
Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer
2018
·
Yiran Liang
, Yaming Li
, et al.
·
Cancer Biology & Therapy
·
76
PDF
circHMCU Promotes Proliferation and Metastasis of Breast Cancer by Sponging the let-7 Family
2020
·
Xiaojin Song
, Yiran Liang
, et al.
·
Molecular Therapy — Nucleic Acids
·
73
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
2021
·
Yuting Sang
, Bing Chen
, et al.
·
Molecular Therapy
·
48
PDF
Plasma extracellular vesicle long RNA profiles in the diagnosis and prediction of treatment response for breast cancer
2021
·
Yonghui Su
, Yuchen Li
, et al.
·
npj Breast Cancer
·
44
PDF
Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective study
2022
·
Yuting Sang
, Xujie Zhou
, et al.
·
Frontiers in Oncology
·
13
PDF
Langer's axillary arch lymph node metastasis in breast cancer patients: A prospective clinical study
2019
·
Yuting Sang
, Xiaoli Kong
, et al.
·
Surgical Oncology
·
12
Treatment and survival outcomes in older women with primary breast cancer: A retrospective propensity score-matched analysis
2022
·
Yuting Sang
, Benlong Yang
, et al.
·
The Breast
·
9
PDF
MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast Cancer
2023
·
Weiru Chi
, Bingqiu Xiu
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
XBP1s Mediates Cross‐resistance to Combination Treatment of CDK4/6 Inhibitors plus Endocrine Therapy in Breast Cancer
2025
·
Yuting Sang
, Shiyang Liu
, et al.
·
Advanced Science
·
2
Comparison of Time-Varying Pattern of Recurrence in Chinese Breast Cancer Patients with Different Molecular Subtypes: A Single-Center Retrospective Study
2022
·
Xu-jie Zhou
, Yu-ting Sang
, et al.
·
ONCOLOGIE
·
2
Correction: circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer
2021
·
Yiran Liang
, Xiaojin Song
, et al.
·
Oncogene
·
2
PDF
Abstract P2-14-02: Surgical options of the breast and clinical outcomes in breast cancer patients after neoadjuvant chemotherapy: a single-center retrospective study
2023
·
Yuting Sang
, Jiajian Chen
, et al.
·
Cancer Research
·
1
Author Correction: Plasma extracellular vesicle long RNA profiles in the diagnosis and prediction of treatment response for breast cancer
2022
·
Yonghui Su
, Yuchen Li
, et al.
·
npj Breast Cancer
·
1
PDF
circHMCU Promotes Proliferation and Metastasis of Breast Cancer by Sponging the let-7 Family
2021
·
Xiaojin Song
, Yiran Liang
, et al.
·
Molecular Therapy — Nucleic Acids
·
1
ESAM reduces sensitivity to anti-HER2 therapy in HER2-positive breast cancer by activating the mTOR pathway
2026
·
Xiaoting Chen
, Xujie Zhou
, et al.
·
Cell Death Discovery
PDF
MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway
2026
·
Hengyu Ren
, Xuliren Wang
, et al.
·
iScience
Show more works
View as search
Works count:
38
Citation count:
2,109
H-index:
13
I10-index:
15
Year
Topic
Type